Q22
About Q22.
Q22 is built for organisations that need more than advice, combining senior commercial judgement with practical execution.
Commercial experience from strategy to patient impact.
Q22 is led by Ivo Schefman, with experience across medical nutrition, pharma, market access, biomaterials, MedTech, drug delivery, venture building and European market development.
Track recordFunding supported, partnerships built, regulated platforms established and ventures brought from concept to patient.
ApproachClear commercial thinking, practical execution and a partner network that helps companies move faster.